These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6981441)

  • 1. Studies on the effect of deoxyadenosine on deoxycoformycin-treated myeloid and lymphoid stem cells.
    Aye MT; Dunne JV; Yang WC
    Blood; 1982 Oct; 60(4):872-6. PubMed ID: 6981441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relative sensitivity of peripheral blood T-lymphocyte colony forming cells and bone marrow CFU-GM to deoxyadenosine and 2'deoxycoformycin.
    Russell NH; Carron J; Hoffbrand AV; Bellingham AJ
    Leuk Res; 1985; 9(2):315-9. PubMed ID: 3872974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of deoxyadenosine toxicity in human lymphoid cells in vitro: relevance to the therapeutic use of inhibitors of adenosine deaminase.
    Lee N; Russell N; Ganeshaguru K; Jackson BF; Piga A; Prentice HG; Foa R; Hoffbrand AV
    Br J Haematol; 1984 Jan; 56(1):107-19. PubMed ID: 6231047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opposite effects of recombinant interferon-alpha A and deoxycoformycin on adenosine deaminase activity in the Daudi B lymphoblastoid cell line.
    Faltynek CR
    Blood; 1988 Jan; 71(1):59-64. PubMed ID: 3257147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced cytotoxicity and inhibition of DNA damage repair in irradiated murine L5178Y lymphoblasts and human chronic lymphocytic leukemia cells treated with 2'-deoxycoformycin and deoxyadenosine in vitro.
    Begleiter A; Pugh L; Israels LG; Johnston JB
    Cancer Res; 1988 Jul; 48(14):3981-6. PubMed ID: 3260129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential use of purine nucleosides and enzyme inhibitors for selective depletion of Thy-lymphoblasts from human bone marrow.
    Russell NH; Hoffbrand AV; Bellingham AJ
    Leuk Res; 1986; 10(3):325-9. PubMed ID: 3081767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elimination of clonogenic malignant human T cells using monoclonal antibodies in combination with 2'-deoxycoformycin.
    Schwartz CL; Minniti CP; Harwood P; Na S; Banquerigo ML; Strauss LC; Kurtzberg J; Smith SD; Civin CI
    J Clin Oncol; 1987 Dec; 5(12):1900-11. PubMed ID: 3500279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of 2'-deoxycoformycin on the metabolism of purines and the survival of malignant cells in a patient with T-cell leukemia.
    Yu AL; Bakay B; Kung FH; Nyhan WL
    Cancer Res; 1981 Jul; 41(7):2677-82. PubMed ID: 6972800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2'Deoxycoformycin and deoxyadenosine affect IL 2 production and IL 2 receptor expression of human T cells.
    Ruers TJ; Buurman WA; van der Linden CJ
    J Immunol; 1987 Jan; 138(1):116-22. PubMed ID: 3097141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of 2'-deoxycoformycin on erythroid, granulocytic, and T-lymphocyte colony growth.
    Aye MT; Dunne JV
    Blood; 1981 Nov; 58(5):1043-6. PubMed ID: 6975136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential sensitivity of leukemic cells to growth inhibition by deoxyadenosine and deoxycoformycin.
    Tanaka M; Kimura K
    Tohoku J Exp Med; 1985 Dec; 147(4):331-41. PubMed ID: 3879563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemolysis in mice treated with deoxycoformycin, an inhibitor of adenosine deaminase.
    Smith CM; Belch A; Henderson JF
    Biochem Pharmacol; 1980 Apr; 29(8):1209-10. PubMed ID: 6966932
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of RNA synthesis by deoxyadenosine plus deoxycoformycin in resting lymphocytes.
    Matsumoto SS; Yu J; Yu AL
    J Immunol; 1983 Dec; 131(6):2762-6. PubMed ID: 6196398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of deoxycoformycin and deoxyadenosine on deoxyribonucleotide concentrations in leukaemic cells.
    Sylwestrowicz T; Piga A; Murphy P; Ganeshaguru K; Russell NH; Prentice HG; Hoffbrand AV
    Br J Haematol; 1982 Aug; 51(4):623-30. PubMed ID: 6980665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of deoxyadenosine on the activation of ADA inhibited T & B cells.
    Webster AD; Ip H; Pereira S
    Clin Exp Immunol; 1982 Dec; 50(3):587-95. PubMed ID: 6299634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Energy metabolism in adenosine deaminase-inhibited human erythrocytes.
    Buc HA; Thuillier L; Hamet M; Garreau F; Moncion A; Pérignon JL
    Clin Chim Acta; 1986 Apr; 156(1):61-9. PubMed ID: 3486057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzyme activities of leukemic cells and biochemical changes induced by deoxycoformycin in vitro--lack of correlation with clinical response.
    Ho AD; Ganeshaguru K; Knauf W; Dietz G; Trede I; Hoffbrand AV; Hunstein W
    Leuk Res; 1989; 13(4):269-78. PubMed ID: 2785618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of an induced adenosine deaminase deficiency on T-cell differentiation in the rat.
    Barton RW
    Cell Immunol; 1985 Oct; 95(2):297-310. PubMed ID: 3876160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of K and NK lymphocyte cytotoxicity by an inhibitor of adenosine deaminase and deoxyadenosine.
    Grever MR; Siaw MF; Coleman MS; Whisler RL; Balcerzak SP
    J Immunol; 1983 Jan; 130(1):365-9. PubMed ID: 6600187
    [No Abstract]   [Full Text] [Related]  

  • 20. Decreased NAD+ content in human T lymphoblastoid cells treated simultaneously with 2'-deoxycoformycin and 2'-deoxyadenosine.
    Koya M; Kanoh T; Uchino H; Ueda K
    Nihon Ketsueki Gakkai Zasshi; 1985 Jul; 48(4):1003-11. PubMed ID: 3877388
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.